evidence: Quik, M., Perez, X. A. & Bordia, T. Nicotine as a potential neuroprotective agent for Parkinson’s disease. Mov. Disord.27, 947–957 (2012). [...] Lu, J. Y. D. et al. The neuroprotective effect of nicotine in Parkinson’s disease models is associated with inhibiting PARP-1 and caspase-3 cleavage. PeerJ2017, (2017). Mouhape, C. et al. Nicotine-induced neuroprotection in rotenone in vivo and in vitro models of Parkinson’s disease: evidences for the involvement of the labile iron pool level as the underlying mechanism. Neurotox. Res.35, 71–82 (2019).